Table 3.
Comparison between clinical and serological features of SSc patients with and without joint erosions
| Erosive arthropathy N = 24 (%) | Non erosive arthropathy N = 22 (%) | P* | |
| SSc subtype | |||
| Diffuse SSc | 77,5 | 51,8 | 0,2 |
| Limited SSc | 22,5 | 48,2 | 0,3 |
| Digital ulcers | 13 | 18 | 0,5 |
| Calcinosis | 4 | 18 | 0,1 |
| Organ involvement | |||
| Lung disease | 58 | 50 | 0,5 |
| Kidney involvement | 4 | 4 | 1 |
| Heart involvement | 21 | 14 | 0,5 |
| Gastro-intestinal involvement | 32 | 42 | 0,9 |
| Associated connectivitis | 21 | 30 | 0,4 |
| RA | 8 | 0 | 0,1 |
| SLE | 4 | 9 | 0,6 |
| Sjögren's Syndrome | 0 | 18 | 0,08 |
| Polymyositis | 8 | 5 | 0,4 |
| Positive rheumatoid factor | 33 | 18 | 0,2 |
| Positive antinuclear antibodies | 46 | 60 | 0,9 |
| Anti topoisomerase I antibody | 4 | 5 | 0,9 |
Values are %
*Comparison between two groups carried out by chi-square test,
RA: rheumatoid arthritis, SLE: systemic lupus erythematosus